Sign in

CIK 0001326110

  • Large accelerated filer

ImmunityBio, Inc.

Sign in to watch
Ticker
IBRX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
431979754
Phone
+1 844-696-5235
Business address
3530 JOHN HOPKINS COURT, SAN DIEGO, CA, 92121
Former names
NantKwest, Inc., Conkwest, Inc., ZelleRx Corp
  1. 4 Open-market sale Chief Financial Officer sold 16,364 shares at $15.00 ($245,460)
  2. 4 Open-market sale Chief Financial Officer sold 39,271 shares at $13.62 ($534,938)
  3. 4 Open-market sale See remarks sold 130,000 shares at $18.05 ($2,346,604)
  4. 4 Open-market sale Director sold 42,592 shares at $10.83 ($461,122)
  5. 3 Insider Initial Statement of Ownership
  6. 4 Open-market sale Director sold 20,000 shares at $9.19 ($183,800)
  7. 4 Open-market sale Director sold 60,000 shares at an average $9.73 ($583,642)
  8. 4 Open-market sale Director sold 30,000 shares at $9.96 ($298,785)
  9. 4 Open-market sale Director sold 65,300 shares at an average $10.23 ($668,052)
  10. 4 Shares withheld for taxes Chief Financial Officer gave up 3,458 shares (to pay taxes)
  11. 4 Open-market sale See remarks sold 130,000 shares at an average $15.53 ($2,019,329)
  12. 4 Open-market sale See remarks sold 39,950 shares at $13.14 ($524,759)
  13. 4 Open-market sale See remarks sold 9 shares at $13.00 ($117)
  14. 4 Open-market buy Chairman and CEO bought 3,710,000 shares at $12.12 ($44,965,200)
  15. 4 Open-market sale See remarks sold 200,041 shares at an average $10.56 ($2,112,950)
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 8 of 13 · 251 filings